Professor Jennifer Whitty is an applied health economist at the University of East Anglia , affiliated with the Norwich Medical School and the Centre of Research Excellence in Telehealth . Her research bridges health economics, patient preferences, and health policy, with a focus on quality of life valuation and economic evaluation. Education: Doctor of Philosophy (Griffith University, 2008), Graduate Diploma in Clinical Pharmacy (University of Queensland, 2002), Bachelor of Pharmacy (University of Wales, 1992) Her work emphasizes person-centered methodologies , particularly discrete choice experiments, to evaluate patient and public preferences for healthcare delivery and outcomes. Key research areas include: Treatment burden and quality of life in chronic diseases like cystic fibrosis Economic evaluation of pharmaceuticals and health technologies Asset-based approaches to community health Priority-setting frameworks in health policy Prof. Whitty has secured over AU$27 million in research funding from organizations including the NHMRC and National Institute for Health and Care Research , and serves on editorial boards for Medical Decision Making and Applied Health Economics and Health Policy .
Professor Khin Than Win is a leading academic in health informatics and digital health at the University of Wollongong (UOW), holding appointments as Professor in the School of Computing and Information Technology, Head of Postgraduate Studies, and Deputy Head (Research). She also serves as Academic Program Director for UOW's Master of Health Informatics and Graduate Certificate in Health Analytics programs. Her research focuses on applying information technology to healthcare, particularly in behavior change support systems, persuasive technology, and ethical AI applications. She has supervised over 20 PhD students and holds leadership roles including Deputy Chair of UOW's Health and Medical Research Ethics Committee, and membership in international committees like the Persuasive Technology Steering Committee. Education: MBBS from Rangoon University, Master's and PhD in IT from Assumption University (Bangkok) and UOW (Australia) Research Interests: Health data analytics, AI in healthcare, privacy/security of health systems Leadership: Program/General Chair roles at ACIS and Persuasive Technology conferences Awards: Best Paper Awards (2023, 2018) Her extensive funding portfolio includes ARC grants and NHMRC projects, totaling over 24 funded initiatives. Current research explores blockchain in medical passports, AI ethics, and culturally tailored health interventions.
Marita Dale is a Senior Lecturer in the Discipline of Physiotherapy at the University of Sydney and an Early Career Researcher affiliated with the Charles Perkins Centre. She specializes in cardiorespiratory physiotherapy, focusing on exercise interventions for chronic respiratory and cardiac diseases, particularly asbestos-related and dust-related conditions. Her work emphasizes improving accessibility to pulmonary rehabilitation services and leveraging mHealth technologies for patient care. Education: PhD in Physiotherapy (2016, University of Sydney). Her research interests include optimizing pulmonary rehabilitation through mobile health platforms, such as the m-PR™ app, and investigating pediatric burn injury rehabilitation, including orthosis use and scar prevention. She also explores multimorbidity management and simulation-based learning in healthcare education. Recent studies have highlighted her contributions to COPD care protocols, telehealth implementation during the pandemic, and qualitative analyses of patient experiences. Major awards: Sydney School of Health Sciences Teaching Citation (2022), Ashurst Prize for Outstanding Oral Presentation (2015), Helga Pettitt FHS Postgraduate Study Award (2010). Marita supervises Honours, Masters, and PhD students, including Mitchell Taylor on airway clearance in bronchiectasis. Her teaching spans undergraduate and postgraduate programs in cardiopulmonary and musculoskeletal physiotherapy. She collaborates on projects like the Lung Support Service, a nationwide text message program for chronic respiratory patients during the pandemic, and contributed to the commercialization of the Perx-R app for pulmonary rehab. Labs/teams: Active member of the Charles Perkins Centre, focusing on interdisciplinary chronic disease research and healthcare innovation.
Dr. Mark Gardner is a Research Fellow in Clinical Imaging at the ACRF Image X Institute, part of the University of Sydney's Sydney School of Health Sciences and Faculty of Medicine and Health. His work focuses on advancing radiation therapy and medical imaging technologies, with particular emphasis on improving treatment accuracy and patient comfort. Gardner holds a PhD from Flinders University, completed in collaboration with the Medical Device Research Institute, and has held research roles at the Cystic Fibrosis Airway Research Group (CFARG). His current projects include the Nano-X radiation therapy device and the Remove the Mask initiative , which aims to eliminate immobilization masks in head and neck cancer treatments. Gardner is affiliated with organizations like the IEEE Engineering in Medicine and Biology Society and the American Association of Physicists in Medicine. Research interests span radiation oncology, translational research in medical imaging, and device innovation. His work integrates advanced imaging techniques (e.g., synchrotron X-rays, cone-beam CT) with machine learning and wearable sensors to address challenges in respiratory therapy and tumor targeting. Notable contributions include developing real-time motion tracking for radiation therapy and improving mucociliary transport measurements. Awards: FameLab 2020 State Finalist, 2018 Medtech e-Challenge Winner, 2017 3MT Runner-Up Grants/Projects: Nano-X radiation therapy development, Remove-the-Mask surface-guided system Collaborations: Industry partnerships, multi-institutional research networks Gardner advises Chen Cheng on real-time head/neck motion monitoring during radiation therapy. His lab contributes to open-source tools and preclinical imaging advancements, bridging engineering and clinical oncology.
Edward Ashworth is a Postdoctoral Research Associate at the Sydney School of Health Sciences, University of Sydney. He is affiliated with the Thermal Ergonomics Laboratory and the Heat and Health Research Incubator. His research focuses on human adaptations to extreme environments, including heat, altitude, hyperbaric conditions, and space-related stressors. Key projects include improving sleep quality in hot environments and enhancing physical work capacity for outdoor workers. Edward's research interests span environmental physiology, with a focus on thermal tolerance, radiation injury mitigation, and the physiological effects of extreme conditions. He has contributed to studies involving nitrogen kinetics tracking using PET imaging, hyperbaric oxygen therapy, and robotic surgery applications. Awards: Young Investigator Award (2023), Art of Science Contest 1st Prize (2024), Australia Space Biology Summit 1st Place (2022), and Sporting Blue (Auckland University of Technology). Associations: The Physiological Society and American Physiological Society. His work integrates clinical trials, statistical research design, and translational approaches to address challenges in environmental health, cardiovascular disease, and healthy ageing. Current projects aim to optimize thermal tolerance strategies for military and occupational settings.
Gabriela Minigo serves as an Honorary Fellow in Global and Tropical Health and Associate Dean - Learning and Teaching within the Faculty of Health. Her academic profile demonstrates active engagement in malaria immunology research with a recent expansion into circadian rhythm and metabolic health investigations. Dr. Minigo completed her PhD at the University of Melbourne (awarded March 31, 2007) and earned a Master of Clinical Epidemiology from the University of Newcastle (awarded December 8, 2017). Her educational background provides a strong foundation in both basic science and clinical epidemiology. Her primary research focuses on immunological responses to malaria, with particular expertise in T follicular helper cells, dendritic cell function, and regulatory T cells in Plasmodium falciparum and Plasmodium vivax infections. Analysis of her research fingerprint reveals significant contributions to Plasmodium falciparum Immunology and Microbiology (100%), Dendritic Cell Immunology and Microbiology (45%), Regulatory T Cell Immunology and Microbiology (38%), and other related fields. In recent years, she has expanded her research to investigate the relationship between photoperiod, circadian rhythm, and metabolic health, as evidenced by her 2024 publications on these topics. Dr. Minigo's scholarly output shows an evolving research trajectory from fundamental malaria immunology toward interdisciplinary investigations connecting circadian biology with metabolic health. Her recent publications (2022-2024) demonstrate continued strong contributions to malaria immunology while incorporating new dimensions related to light exposure, sleep patterns, and glucose control. She has secured research funding for multiple projects including 'Rainmaker start up- Does exposure to artificial light alter circadian rhythm and glucose control in Australian adults? A pilot study' (2023-2026) where she serves as Co-Investigator, and 'Effect of Extended Photoperiod Exposure on Circadian Rhythm and Glucose Control' (2024-present) where she is Principal Investigator. Previously, she contributed as Chief Investigator C to 'Manipulating T follicular helper cells to improve human malaria vaccines' (2020-2023). As Associate Dean for Learning and Teaching, Dr. Minigo holds significant educational leadership responsibilities within the Faculty of Health. She is registered to supervise postgraduate research, indicating her active role in mentoring graduate students in immunology and tropical medicine research.
Owen Price is an Associate Professor and Director in Bushfire Risk Management at the School of Earth, Atmospheric and Life Sciences (SEALS), University of Wollongong. His roles include leading research on wildfire impacts on ecosystems, human health, and infrastructure. He holds a PhD from the Australian National University (1998), an MSc from the University of Strathclyde (1986), and a BSc (hons) from the University of York (1985). Director, Centre for Environmental Risk Management of Bushfire (since 2020) Principal Fellow, SEALS (2019–2021) His research integrates fieldwork, GIS/remote sensing, and statistical modeling to address landscape-scale wildfire risks. Key interests include fire severity effects on biodiversity, smoke pollution impacts, and cost-effective fire management strategies. He supervises postgraduate students in topics like coastal wetland vulnerability and fire regime analysis. Recent grants include studies on coastal wetlands' fire resilience (2023–2026), Bayesian fire spread modeling (2023–2026), and evaluating aerial firefighting efficacy (2023). His work bridges ecological, social, and technical dimensions of wildfire risk. Notable awards and recognitions are not explicitly listed in the provided materials. His contributions to fire policy and community adaptation are highlighted through collaborative projects with government and environmental agencies.
Professor Hilary Bambrick is a distinguished environmental epidemiologist and anthropologist at the Australian National University (ANU), leading the National Centre for Epidemiology and Population Health. She specializes in climate change and health, focusing on adaptation strategies, vector-borne diseases, and urban resilience. Her work bridges research, policy, and practice, with significant contributions to global health initiatives like the WHO and UNDP. Bambrick has over 180 publications and $11M in research funding, addressing climate impacts on vulnerable populations, including First Nations communities and Pacific Island nations. She serves on the Climate Council of Australia and the Australia Institute, advocating for evidence-based climate policies. Her research integrates epidemiology, anthropology, and environmental science to enhance health resilience in changing climates. Education: PhD (ANU, 2003), BA (Hons), BSc, Grad Cert Higher Ed. Key Research Focus: Climate change health impacts, adaptation strategies, vector-borne diseases, urban design, and health equity. She leads interdisciplinary projects on climate litigation, heatwaves, and infectious disease forecasting. Grants & Funding: Over $11 million in research grants, including projects on bushfire preparedness, dengue transmission modeling, and climate-sensitive disease surveillance. Labs/Teams: National Centre for Epidemiology and Population Health (ANU), collaborating with global networks like the Lancet Countdown and MJA-Lancet Countdown.
Anne Holland is Professor of Physiotherapy and Head of Respiratory Research at Monash University and Alfred Health in Melbourne, Australia. She is an NHMRC Leadership Fellow (2021–2025) and a Chief Investigator for the NHMRC Centre of Research Excellence in Pulmonary Fibrosis and the NHMRC Centre of Research Excellence in Treatable Traits. Her research focuses on supportive therapies for chronic respiratory diseases, particularly COPD and pulmonary fibrosis, with a strong emphasis on pulmonary rehabilitation, telerehabilitation, and ambulatory oxygen therapy. Her research interests include: Respiratory physiotherapy Pulmonary rehabilitation (home-based and low-cost models) Access to care for chronic lung disease Telerehabilitation and digital health Symptom management in interstitial lung disease Exercise training and physical activity promotion Her recent publications focus on symptom management, digital self-management tools, treatable traits models, and clinical trials in pulmonary fibrosis and COPD. The body of work reflects a strong trend toward patient-centered, accessible, and evidence-based interventions that improve quality of life and clinical outcomes in chronic respiratory conditions. Her major scientific awards include: Society Medal, Thoracic Society of Australia and New Zealand (2021) European Respiratory Society Gold Medal for Allied Health Professionals (2022) NHMRC Investigator Fellow (Leadership 1) (2021) Fellow, Thoracic Society of Australia and New Zealand (2019) American Thoracic Society Pulmonary Rehabilitation Assembly Award (2016) Anne Holland supervises PhD students and is actively involved in advising and grant leadership. She is the Primary Chief Investigator on major trials such as the PERFORM trial and the TAPPET trial, and she leads a multinational ambulatory oxygen trial for fibrotic lung disease. Her work is supported by NHMRC and international collaborations. She is also President of the Thoracic Society of Australia and New Zealand, reflecting her leadership in the field. Anne leads the Holland Respiratory Care Research Group at Monash, which focuses on innovative models of care delivery, validation of remote monitoring tools, and improving patient self-management in chronic lung disease. The team collaborates widely across Australia and internationally, particularly in trials involving pulmonary rehabilitation and treatable traits.
Giel van Dooren is an Associate Professor at the Research School of Biology , Australian National University. His research focuses on the cell biology and metabolism of apicomplexan parasites , particularly Toxoplasma gondii and Plasmodium falciparum , aiming to develop novel therapeutic strategies against these pathogens. Education: Bachelor of Arts/Bachelor of Science (University of Melbourne, 2000), PhD (University of Melbourne, 2005) His work explores three core areas: Nutrient acquisition (plasma membrane transporters), Mitochondrial biology (electron transport chain inhibitors, apicoplast-mitochondrion metabolic integration), and Toxoplasma life cycle (felid host genetics). Collaborations include Kiaran Kirk , Adele Lehane , Alex Maier , and Kevin Saliba . Recent publications highlight advancements in understanding mitochondrial transporter functions , divergent respiratory complexes , and nutrient pathway drug targets . His lab actively seeks innovative tools for combating parasitic diseases through molecular physiology and metabolomics. Scientific Awards: College of Science Dean’s Commendation for Excellence in Education - Teaching Excellence (2024) College of Science Dean’s Commendation for Excellence in Education - Outstanding Contribution to Student Learning (2023) Bancroft-Mackerras Medal of the Australian Society for Parasitology (2021) College of Science Dean’s Commendation for Excellence in Education (2020, 2020) Grants & Projects: Na+-dysregulating antimalarials: PfATP4 physiology (2024-2027) Metal transporters in Toxoplasma gondii (2023-2026) Amino acid acquisition in Apicomplexans (2023-2025) Targeting mitochondrial ETC in parasites (2020-2023) Regulating nutrient uptake in intracellular parasites (2020-2022)
Kaye Morgan is an Associate Professor in the School of Physics and Astronomy at Monash University, specializing in X-ray imaging technologies with applications in medical and respiratory research. She holds an Australian Research Council Future Fellowship and has held prestigious positions including a Hans Fischer Fellowship at Technische Universität München. Her research focuses on advancing X-ray optics methodologies, particularly phase contrast X-ray imaging (PCXI) and dark-field imaging, to enhance resolution, speed, and sensitivity. These techniques are applied to study airway health in cystic fibrosis and other respiratory diseases, using synchrotron facilities like SPring-8 and the Munich Compact Light Source. She has pioneered single-grid imaging and propagation-based dark-field approaches, enabling real-time visualization of lung dynamics and treatment efficacy. Morgan leads multiple high-impact projects funded by ARC and international collaborations, with over 85 publications in journals like Optics Express and Scientific Reports. Her work contributes to UN Sustainable Development Goals related to health and innovation. Key achievements include developing lab-based X-ray sources for clinical translation and quantifying lung microstructure through advanced imaging algorithms.
Fabio Zanini is an Associate Professor at the University of New South Wales (UNSW) , leading a research group focused on computational biology , single-cell approaches , and transcriptomic analysis across diseases like severe dengue , neonatal lung disease , cancer , and marine biology . He previously conducted postdoctoral research at Stanford University (2016-2019) and earned a PhD in Bioinformatics from the Max Planck Institute for Developmental Biology and the University of Tuebingen (2015). Current Affiliation: Group leader, UNSW Previous Training: Postdoc (Stanford), PhD (Max Planck/University of Tuebingen) His research spans single-cell RNA sequencing , computational virology , developmental cell biology , and bioinformatics tool development , with recent work on: Severe dengue progression (viral-host interactions, immune signatures) Lung development (endothelial cell diversity, hyperoxia-induced injury) Cancer genomics (mutant HSC clones, AZA therapy response) Marine biology (plankton transcriptomics, evolutionary analysis) Bioinformatics (HTSeq 2.0, northstar algorithm) Recent scientific awards include grants from the Chan Zuckerberg Initiative ($270,000), NIH R01 (multiple), ARC Discovery Grant , and NHMRC Ideas Grant . Notable contributions include: Northstar - Cell classification algorithm SpectralSeq - Hyperspectral-transcriptomic integration Tabula Muris - Mouse aging atlas He has supervised research into hematopoietic stem cell regulation , lung vascular development , and autophagy in viral infections , with collaborations across Stanford , University of Sydney , and Harvard .
Associate Professor Aditi Dey holds a conjoint appointment at the Sydney Medical School within the University of Sydney , and serves as Manager of Surveillance at the National Centre for Immunisation Research and Surveillance (NCIRS) . Her work focuses on immunization program evaluation, vaccine coverage analysis, and surveillance of vaccine-preventable diseases and adverse events. She has extensive experience in public health research, spanning roles in Thailand and India prior to her current positions in Australia. Dr Dey completed an MBBS, followed by postgraduate qualifications including a DTM&H (Tropical Medicine & Hygiene), Grad Dip Applied Science (Health Information Management), MPH, and a PhD from the University of Sydney. Her research integrates epidemiological analysis with public health policy implementation, particularly addressing health disparities in vaccination access and outcomes among Indigenous populations and other underserved groups. Her research interests prominently feature vaccine safety , epidemiological trends of infectious diseases, and the impact of vaccination policies such as Australia’s “No Jab, No Pay” initiative. She also investigates the effectiveness of vaccination programs for diseases like rotavirus, HPV, and varicella-zoster virus, often analyzing large-scale national health datasets. Notable contributions include evaluations of Australia’s HPV vaccination program, analysis of rotavirus vaccine efficacy, and assessments of adverse events following immunization. Her work emphasizes improving immunization coverage through better data systems and healthcare provider education, particularly for at-risk populations. Dr Dey actively contributes to public health efforts through teaching and course coordination at the University of Sydney, and collaborates with institutions like the Sydney Infectious Diseases Institute . Her expertise bridges clinical practice, research, and policy, driving evidence-based improvements in Australia’s immunization landscape.
Rachel Huxley is Deakin Distinguished Professor and Executive Dean of the Faculty of Health at Deakin University, a role she has held since October 2019. She leads the Faculty of Health and is based at the Melbourne Burwood Campus. She previously served as Associate Pro-Vice Chancellor (Research) at La Trobe University, Chair in Epidemiology at the University of Queensland, and Head of the School of Public Health at Curtin University. She holds honorary appointments at the George Institute for Global Health (UNSW) and the Nuffield Department of Population Health, University of Oxford. Education: Undergraduate studies at St John's College, Oxford Doctorate in Epidemiology and Public Health, Department of Public Health and Primary Care, Oxford University Post-doctoral training at Oxford University Professor Huxley's research centers on epidemiology and public health, with a focus on chronic disease risk factors, sex and ethnic disparities, and the health impacts of climate change and air pollution. Her work spans cardiovascular disease, obesity, diabetes, women's health, and environmental determinants of health. She has published over 200 research articles and maintains an h-index of 58 (Web of Science). The 15 most recent publications reflect a strong interdisciplinary focus on environmental health, mental health, cardiometabolic disease, and health policy. Key themes include air pollution and child obesity, climate change and asthma, green space and psychiatric disorders, and sex disparities in coronary heart disease care. Her research increasingly integrates planetary health, policy reform, and equity considerations. Scientific Awards and Fellowships: Inaugural Career Development Fellowship from the Heart Foundation and NSW Office for Science and Medical Research Career Development Award ($400K) from NSW and National Heart Foundation of Australia (2009–2010) Professor Huxley has secured over $2.5 million as Chief Investigator A and contributed to more than $5 million in co-investigator grants. Current and recent projects include NHMRC-funded studies on obesity, prediabetes, electronic cigarettes, women's health data, CT scanning risks, and coronary heart disease management. She supervises several doctoral students and is actively involved in national and international advisory boards, including the Telethon Kids Institute and the Australian Clinical Trials Alliance. She leads or contributes to major research initiatives such as the Centre of Research Excellence on Women and Non-communicable Disease (CRE WaND) and the Breathe Melbourne citizen science project. Her leadership extends to policy engagement, with research influencing public health strategies on air quality, climate change, and sex and gender equity in research.
Dr. Michael Stevens is a Senior Lecturer at University of New South Wales (UNSW) Canberra , where he focuses on advanced manufacturing and biomedical device control systems . His work bridges digital manufacturing for SMEs with smart artificial heart technologies , emphasizing industry collaboration and translational research. Specializes in physiological control systems for rotary blood pumps Develops unobtrusive fall detection systems for dementia patients Leads international projects on total artificial heart development Education : B.Eng (Medical - First Class Honours), Queensland University of Technology (2010) PhD in Physiological Control for Biventricular Assist Devices, University of Queensland (2014) Research Trends show consistent focus on: Machine learning for biomedical diagnostics (2018–2025) mmWave radar and thermal sensors in patient monitoring (2021–2024) Computational fluid dynamics in artificial heart modeling (2016–2024) Physiological control algorithms for rotary blood pumps (2011–2025) Scientific Awards : UNSW Scientia Education Award (2021) for contextual teaching Heart Foundation Runner-up for "Smart Artificial Hearts" pitch (2021) ARC PGC Supervisor Award (2017) for mentoring Grants & Supervision : Holds over $6 million in competitive funding including MRFF and ARC grants. Currently supervises 4 PhD students while maintaining industry partnerships with VitalCare and BiVACOR. Labs & Facilities : Works across UNSW Engineering labs and Graduate School of Biomedical Engineering platforms, including mock circulation loops and high-performance computing clusters for CFD simulations.
